• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infection . Role and benefits of infectious diseases specialists in the COVID-19 pandemic: Multilevel analysis of care provision in German hospital

tetano

Editor, Senior Moderator
Infection


. 2024 Aug 16.
doi: 10.1007/s15010-024-02362-2. Online ahead of print. Role and benefits of infectious diseases specialists in the COVID-19 pandemic: Multilevel analysis of care provision in German hospitals using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS) cohort

Lene T Tscharntke[SUP] 1 [/SUP], Norma Jung[SUP] 1 [/SUP], Frank Hanses[SUP] 2 [/SUP], Carolin E M Koll[SUP] 3 4 [/SUP], Lisa Pilgram[SUP] 5 6 [/SUP], Siegbert Rieg[SUP] 7 [/SUP], Stefan Borgmann[SUP] 8 [/SUP], Susana M Nunes de Miranda[SUP] 3 [/SUP], Margarete Scherer[SUP] 3 [/SUP], Christoph D Spinner[SUP] 9 [/SUP], Maria Rüthrich[SUP] 10 [/SUP], Maria J G T Vehreschild[SUP] 4 11 [/SUP], Michael von Bergwelt-Baildon[SUP] 12 [/SUP], Kai Wille[SUP] 13 [/SUP], Uta Merle[SUP] 14 [/SUP], Martin Hower[SUP] 15 [/SUP], Katja Rothfuss[SUP] 16 [/SUP], Silvio Nadalin[SUP] 17 [/SUP], Hartwig Klinker[SUP] 18 [/SUP], Julia Fürst[SUP] 19 [/SUP], Ingo Greiffendorf[SUP] 20 [/SUP], Claudia Raichle[SUP] 21 [/SUP], Anette Friedrichs[SUP] 22 [/SUP], Dominic Rauschning[SUP] 23 [/SUP], Katja de With[SUP] 24 [/SUP], Lukas Eberwein[SUP] 25 [/SUP], Christian Riedel[SUP] 26 [/SUP], Milena Milovanovic[SUP] 27 [/SUP], Maximilian Worm[SUP] 28 [/SUP], Beate Schultheis[SUP] 29 [/SUP], Jörg Schubert[SUP] 30 [/SUP], Marc Bota[SUP] 31 [/SUP], Gernot Beutel[SUP] 32 [/SUP], Thomas Glück[SUP] 33 [/SUP], Michael Schmid[SUP] 34 [/SUP], Tobias Wintermantel[SUP] 35 [/SUP], Helga Peetz[SUP] 36 [/SUP], Stephan Steiner[SUP] 37 [/SUP], Elena Ribel[SUP] 38 [/SUP], Harald Schäfer[SUP] 39 [/SUP], Jörg Janne Vehreschild[SUP] #[/SUP][SUP] 40 41 42 [/SUP], Melanie Stecher[SUP] #[/SUP][SUP] 3 4 [/SUP]; LEOSS Study Group



Affiliations
Abstract

Purpose: This study investigates the care provision and the role of infectious disease (ID) specialists during the coronavirus disease-2019 (COVID-19) pandemic.
Methods: A survey was conducted at German study sites participating in the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS). Hospitals certified by the German Society of Infectious diseases (DGI) were identified as ID centers. We compared care provision and the involvement of ID specialists between ID and non-ID hospitals. Then we applied a multivariable regression model to analyse how clinical ID care influenced the mortality of COVID-19 patients in the LEOSS cohort.
Results: Of the 40 participating hospitals in the study, 35% (14/40) were identified as ID centers. Among those, clinical ID care structures were more commonly established, and ID specialists were always involved in pandemic management and the care of COVID-19 patients. Overall, 68% (27/40) of the hospitals involved ID specialists in the crisis management team, 78% (31/40) in normal inpatient care, and 80% (28/35) in intensive care. Multivariable analysis revealed that COVID-19 patients in ID centers had a lower mortality risk compared to those in non-ID centers (odds ratio: 0.61 (95% CI 0.40-0.93), p = 0.021).
Conclusion: ID specialists played a crucial role in pandemic management and inpatient care.

Keywords: COVID-19; Healthcare quality; Healthcare research; Infectious diseases medicine; Pandemic; Quality indicators.

 
Back
Top